Giant cell tumor of the uterus: Case report and response to chemotherapy

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Skubitz, Keith M ^a   Carlos, J Carlos ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CD68 ANTIGEN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; LEVOTHYROXINE; LISINOPRIL; MESNA; MITOMYCIN C; MULTIVITAMIN; PEROXIDASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR RECEPTOR; ALKYLATING AGENT; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC ANTIBIOTIC; MONOCLONAL ANTIBODY;

ABDOMINAL HYSTERECTOMY; ADULT; ANOREXIA; ARTICLE; ASPIRATION BIOPSY; BONE MARROW SUPPRESSION; CASE REPORT; CELL SUBPOPULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; COUGHING; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG RESPONSE; DYSPNEA; FATIGUE; FEMALE; GIANT CELL TUMOR; GOUT; HUMAN; HYPERTENSION; HYPOTHYROIDISM; LUNG METASTASIS; LUNG NODULE; MITOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MONONUCLEAR CELL; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OSTEOCLAST; PROTEINURIA; SALPINGOOOPHORECTOMY; TUMOR GROWTH; UTERUS BLEEDING; UTERUS TUMOR; VAGINA BLEEDING; WEIGHT REDUCTION; HYSTERECTOMY; LUNG TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REVIEW; TREATMENT OUTCOME; UTERUS CANCER;

ANGIOGENESIS INHIBITORS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; GIANT CELL TUMORS; HUMANS; HYSTERECTOMY; IFOSFAMIDE; LUNG NEOPLASMS; MIDDLE AGED; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 33947689218     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-46     Document Type: Article

References (57)

1. Athanasou NA Bliss E Gatter KC Heryet A Woods CG McGee JO An immunohistological study of giant-cell tumour of bone: Evidence for an osteoclast origin of the giant cells J Pathol 1985 147 153-158 10.1002/ path.1711470302 4067733
2. Goldring SR Roelke MS Petrison KK Bhan AK Human giant cell tumors of bone identification and characterization of cell types J Clin Invest 1987 79 483-491 424109 3027126
3. Zheng MH Fan Y Smith A Wysocki S Papadimitriou JM Wood DJ Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: Possible involvement in CD68+ macrophage-like cell migration J Cell Biochem 1998 70 121-129 10.1002/ (SICI)1097-4644(19980701)70:1<121::AID-JCB12>3.0.CO;2-S 9632113
4. Walker DG Congenital osteopetrosis in mice cured by parabiotic union with normal siblings Endocrinology 1972 91 916-920 5051344
5. Walker DG Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells Science 1975 190 784-785 10.1126/ science.1105786 1105786
6. Roux S Amazit L Meduri G Guiochon-Mantel A Milgrom E Mariette X RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone Am J Clin Pathol 2002 117 210-216 10.1309/BPET-F2PE-P2BD-J3P3 11863217
7. Tubbs WS Brown LR Beabout JW Rock MG Unni KK Benign giant-cell tumor of bone with pulmonary metastases: Clinical findings and radiologic appearance of metastases in 13 cases AJR Am J Roentgenol 1992 158 331-334 1729794
8. Skubitz KM Hamdan H Thompson RC Jr. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas Cancer 1993 72 2963-2969 10.1002/ 1097-0142(19931115)72:10<2963::AID-CNCR2820721017>3.0.CO;2-W 8221562
9. Okuno S Edmonson J Mahoney M Buckner JC Frytak S Galanis E Phase II trial of gemcitabine sarcomas Cancer 2002 94 3225-3229 10.1002/ cncr.10602 12115355
10. Patel SR Gandhi V Jenkins J Papadopolous N Burgess MA Plager C Plunkett W Benjamin RS Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation J Clin Oncol 2001 19 3483-3489 11481354
11. Northfelt DW Dezube BJ Thommes JA Miller BJ Fischl MA Friedman-Kien A Kaplan LD Du Mond C Mamelok RD Henry DH Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial J Clin Oncol 1998 16 2445-2451 9667262
12. Skubitz KM Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma Cancer Invest 2003 21 167-176 10.1081/CNV-120016412 12743981
13. Skubitz KM Haddad PA Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma Cancer 2005 104 361-366 10.1002/cncr.21140 15948172
14. Judson I Radford JA Harris M Blay JY van Hoesel Q le Cesne A van Oosterom AT Clemons MJ Kamby C Hermans C Whittaker J Donato di Paola E Verweij J Nielsen S Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: A study by the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 2001 37 870-877 10.1016/ S0959-8049(01)00050-8 11313175
15. Patel SR Vadhan-Raj S Papadopolous N Plager C Burgess MA Hays C Benjamin RS High-dose ifosfamide in bone and soft tissue sarcomas: Results of phase II and pilot studies--dose-response and schedule dependence J Clin Oncol 1997 15 2378-2384 9196153
16. Zheng MH Xu J Robbins P Pavlos N Wysocki S Kumta SM Wood DJ Papadimitriou JM Gene expression of vascular endothelial growth factor in giant cell tumors of bone Hum Pathol 2000 31 804-812 10.1053/ hupa.2000.8441 10923916
17. Skubitz KM Skubitz AP Characterization of sarcomas by means of gene expression J Lab Clin Med 2004 144 78-91 10.1016/j.lab.2004.04.005 15322502
18. Skubitz KM Cheng EY Clohisy DR Thompson RC Skubitz AP Gene expression in giant-cell tumors J Lab Clin Med 2004 144 193-200 10.1016/ j.lab.2004.06.005 15514587
19. Kumta SM Huang L Cheng YY Chow LT Lee KM Zheng MH Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions Life Sci 2003 73 1427-1436 10.1016/S0024-3205(03)00434-X 12850503
20. Hoang BH Dyke JP Koutcher JA Huvos AG Mizobuchi H Mazza BA Gorlick R Healey JH VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI Clin Orthop Relat Res 2004 32-38 10.1097/ 01.blo.0000141492.52166.20 15346048
21. Heymach JV Desai J Manola J Davis DW McConkey DJ Harmon D Ryan DP Goss G Quigley T Van den Abbeele AD Silverman SG Connors S Folkman J Fletcher CD Demetri GD Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas Clin Cancer Res 2004 10 5732-5740 10.1158/1078-0432.CCR-04-0157 15355900
22. Hayes AJ Mostyn-Jones A Koban MU A'Hern R Burton P Thomas JM Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma Br J Surg 2004 91 242-247 10.1002/bjs.4398 14760675
23. Graeven U Andre N Achilles E Zornig C Schmiegel W Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma J Cancer Res Clin Oncol 1999 125 577-581 10.1007/s004320050319 10473871
24. Niida S Kaku M Amano H Yoshida H Kataoka H Nishikawa S Tanne K Maeda N Kodama H Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption J Exp Med 1999 190 293-298 10.1084/jem.190.2.293 10432291
25. van Haelst UJ de Haas van Dorsser AH Giant cell tumor of soft parts. An ultrastructural study Virchows Arch A Pathol Anat Histol 1976 371 199-217 10.1007/BF00433068 184582
26. Dodd LG Major N Brigman B Malignant giant cell tumor of soft parts Skeletal Radiol 2004 33 295-299 10.1007/s00256-003-0744-8 14997349
27. Silverberg SG DeGiorgi LS Osteoclastoma-like giant cell tumor of the thyroid. Report of a case with prolonged survival following partial excision and radiotherapy Cancer 1973 31 621-625 10.1002/ 1097-0142(197303)31:3<621::AID-CNCR2820310319>3.0.CO;2-N 4693590
28. Rosai J Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin Cancer 1968 22 333-344 10.1002/ 1097-0142(196808)22:2<333::AID-CNCR2820220210>3.0.CO;2-A 5660199
29. Trepeta RW Mathur B Lagin S LiVolsi VA Giant cell tumor ("osteoclastoma") of the pancreas: A tumor of epithelial origin Cancer 1981 48 2022-2028 10.1002/ 1097-0142(19811101)48:9<2022::AID-CNCR2820480919>3.0.CO;2-I 7296510
30. Caudell JJ Ballo MT Zagars GK Lewis VO Weber KL Lin PP Marco RA El-Naggar AK Benjamin RS Yasko AW Radiotherapy in the management of giant cell tumor of bone Int J Radiat Oncol Biol Phys 2003 57 158-165 10.1016/S0360-3016(03)00416-4 12909228
31. Feigenberg SJ Marcus RB Jr. Zlotecki RA Scarborough MT Enneking WF Whole-lung radiotherapy for giant cell tumors of bone with pulmonary metastases Clin Orthop Relat Res 2002 202-208 10.1097/ 00003086-200208000-00023 12151897
32. Osaka S Toriyama M Taira K Sano S Saotome K Analysis of giant cell tumor of bone with pulmonary metastases Clin Orthop Relat Res 1997 253-261 9020226
33. Maloney WJ Vaughan LM Jones HH Ross J Nagel DA Benign metastasizing giant-cell tumor of bone. Report of three cases and review of the literature Clin Orthop Relat Res 1989 208-215 2656024
34. Bertoni F Present D Sudanese A Baldini N Bacchini P Campanacci M Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature Clin Orthop Relat Res 1988 275-285 3056645
35. Bertoni F Present D Enneking WF Giant-cell tumor of bone with pulmonary metastases J Bone Joint Surg Am 1985 67 890-900 4019539
36. Sanjay BK Kadhi SM Giant cell tumour of bone with pulmonary metastases. A report of three cases Int Orthop 1998 22 200-204 10.1007/s002640050242 9728318
37. Stewart DJ Belanger R Benjamin RS Prolonged disease-free survival following surgical debulking and high-dose cisplatin/doxorubicin in a patient with bulky metastases from giant cell tumor of bone refractory to "standard" chemotherapy Am J Clin Oncol 1995 18 144-148 7900706
38. Yamamoto M Fukushima T Sakamoto S Tomonaga M Giant cell tumor of the sphenoid bone: Long-term follow-up of two cases after chemotherapy Surg Neurol 1998 49 547-552 10.1016/S0090-3019(97)00219-X 9586934
39. Kay RM Eckardt JJ Seeger LL Mirra JM Hak DJ Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression Clin Orthop Relat Res 1994 219-230 8168305
40. Lachat MR Weber M Cserhati MD Honegger HP von Hochstetter AR [Giant cell tumor of bone with rapid malignant course] Orthopade 2004 33 344-348 10.1007/s00132-003-0554-7 15007559
41. De Smedt M Copin G Boeri C Dosch JC Dupuis M Marcellin L [A case of a aggressive giant-cell tumor with multiple bone metastases] Rev Chir Orthop Reparatrice Appar Mot 1999 85 293-296 10422135
42. Kaban LB Troulis MJ Ebb D August M Hornicek FJ Dodson TB Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws J Oral Maxillofac Surg 2002 60 1103-11; discussion 1111-3 10.1053/ joms.2002.34975 12378481
43. Kaiser U Neumann K Havemann K Generalised giant-cell tumour of bone: successful treatment of pulmonary metastases with interferon alpha, a case report J Cancer Res Clin Oncol 1993 119 301-303 10.1007/BF01212729 8440744
44. Dickerman JD Interferon and giant cell tumors Pediatrics 1999 103 1282-1283 10.1542/peds.103.6.1282 10353942
45. Magni E Lauritzen AF Wilken-Jensen C Horn T Malignant giant cell tumour of the uterus APMIS Suppl 1991 23 113-118 1883635
46. Sieinski W Malignant giant cell tumor associated with leiomyosarcoma of the uterus Cancer 1990 65 1838-1842 10.1002/ 1097-0142(19900415)65:8<1838::AID-CNCR2820650829>3.0.CO;2-1 2317762
47. Watanabe K Hiraki H Ohishi M Mashiko K Saginoya H Suzuki T Uterine leiomyosarcoma with osteoclast-like giant cells: Histopathological and cytological observations Pathol Int 1996 46 656-660 8905874
48. Egorov VP Naumov VN [Malignant giant cell uterine tumors] Arkh Patol 1983 45 78-82 6847417
49. Kindblom LG Seidal T Malignant giant cell tumor of the uterus. A clinico-pathologic, light- and electron-microscopic study of a case Acta Pathol Microbiol Scand [A] 1981 89 179-184 7270164
50. Darby AJ Papadaki L Beilby JO An unusual leiomyosarcoma of the uterus containing osteoclast-like giant cells Cancer 1975 36 495-504 10.1002/ 1097-0142(197508)36:2<495::AID-CNCR2820360228>3.0.CO;2-I 50874
51. Pilon VA Parikh N Maccera J Malignant osteoclast-like giant cell tumor associated with a uterine leiomyosarcoma Gynecol Oncol 1986 23 381-386 10.1016/0090-8258(86)90142-3 3957125
52. Huang L Xu J Wood DJ Zheng MH Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: Possible involvement in tumor cell-induced osteoclast-like cell formation Am J Pathol 2000 156 761-767 10702390
53. Kong YY Feige U Sarosi I Bolon B Tafuri A Morony S Capparelli C Li J Elliott R McCabe S Wong T Campagnuolo G Moran E Bogoch ER Van G Nguyen LT Ohashi PS Lacey DL Fish E Boyle WJ Penninger JM Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 1999 402 304-309 10.1038/46303 10580503
54. Atkins GJ Haynes DR Graves SE Evdokiou A Hay S Bouralexis S Findlay DM Expression of osteoclast differentiation signals by stromal elements of giant cell tumors J Bone Miner Res 2000 15 640-649 10.1359/ jbmr.2000.15.4.640 10780856
55. Lacey DL Timms E Tan HL Kelley MJ Dunstan CR Burgess T Elliott R Colombero A Elliott G Scully S Hsu H Sullivan J Hawkins N Davy E Capparelli C Eli A Qian YX Kaufman S Sarosi I Shalhoub V Senaldi G Guo J Delaney J Boyle WJ Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 1998 93 165-176 10.1016/ S0092-8674(00)81569-X 9568710
56. Chang SS Suratwala SJ Jung KM Doppelt JD Zhang HZ Blaine TA Kim TW Winchester RJ Lee FY Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis Clin Orthop Relat Res 2004 103-109 10.1097/ 01.blo.0000141372.54456.80 15346059
57. Cheng YY Huang L Lee KM Xu JK Zheng MH Kumta SM Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone Calcif Tissue Int 2004 75 71-77 10.1007/s00223-004-0120-2 15037971